Systematic Optimization of Activity-Based Protein Profiling for Identification of Polysorbate-Degradative Enzymes in Biotherapeutic Drug Substance Down to 10 ppb

Taku Tsukidate,Anita P Liu,Shannon Rivera,Alyssa Q Stiving,Jonathan Welch,Xuanwen Li

DOI: https://doi.org/10.1101/2024.08.29.610306

2024-11-08

Abstract:The identification and control of high-risk host cell proteins (HCPs) in biotherapeutics development is crucial for ensuring product quality and shelf life. Specifically, HCPs with hydrolase activity can cause degradation of excipient polysorbates (PS), leading to a decrease in the shelf life of the drug product. In this study, we systematically optimized every step of an activity-based protein profiling (ABPP) workflow to identify trace amounts of active polysorbate-degradative enzymes (PSDEs) in biotherapeutics process intermediates. Evaluation of various parameters during sample preparation pinpointed optimal pH level and fluorophosphonate (FP)-biotin concentration. Moreover, the combined use of a short liquid chromatography gradient and the fast-scanning Parallel Accumulation Serial Fragmentation (PASEF) methodology increased sample throughput without compromising identification coverage. Tuning Trapped Ion Mobility Spectrometry (TIMS) parameters further enhanced sensitivity. In addition, we evaluated various data acquisition modes including PASEF combined with data-dependent acquisition (DDA PASEF), data-independent acquisition (diaPASEF), or parallel reaction monitoring (prm-PASEF) as well as data processing strategies. By employing the newly optimized ABPP workflow, we successfully identified PSDEs at a concentration as low as 10 parts per billion (ppb) in a drug substance sample. Finally, the new workflow enabled us to detect a PSDE that could not be detected with the original workflow during a PS degradation root-cause investigation.

Bioengineering

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to identify and control high - risk host cell proteins (HCPs) in biotherapeutic drugs, especially those HCPs with hydrolytic activity that can degrade the formulation excipient polysorbate (PS), thereby shortening the shelf - life of drug products. Specifically, the researchers systematically optimized each step of the activity - based protein profiling (ABPP) workflow to identify active polysorbate - degrading enzymes (PSDEs) at concentrations as low as 10 ppb in biotherapeutic drug intermediates. Through this optimized workflow, the researchers successfully identified PSDEs at concentrations as low as 10 ppb in drug substance samples, and in a root - cause investigation of polysorbate degradation, detected a PSDE that was not detected by the previous workflow. This new method improves the understanding of the causes of PS degradation and helps to guide control strategies for PS degradation, such as downstream purification, upstream cell - culture optimization, and potential gene knockout during cell - line development.

Systematic Optimization of Activity-Based Protein Profiling for Identification of Polysorbate-Degradative Enzymes in Biotherapeutic Drug Substance Down to 10 ppb

Identification and Quantification of a Problematic Host Cell Protein to Support Therapeutic Protein Development.

Identification of Acyl-Protein Thioesterase-1 as a Polysorbate-degrading Host Cell Protein in a Monoclonal Antibody Formulation Using Activity-based Protein Profiling

The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation

Activity-Based Protein Profiling Probe for the Detection of Enzymes Catalyzing Polysorbate Degradation

Illuminating a biologics development challenge: systematic characterization of CHO cell-derived hydrolases identified in monoclonal antibody formulations

An integral activity-based protein profiling (IABPP) method for higher throughput determination of protein target sensitivity to small molecules

Site-Specific Activity-Based Protein Profiling Using Phosphonate Handles

Monitoring polysorbate hydrolysis in therapeutic proteins using an ultrasensitive extraction-free fatty acid quantitation method

High-Throughput, Fluorescence-Based Esterase Activity Assay for Assessing Polysorbate Degradation Risk during Biopharmaceutical Development

Detailed profiling of polysorbate 80 oxidative degradation products and hydrolysates using liquid chromatography–tandem mass spectrometry analysis

diaPASEF Enables High-throughput Proteomic Analysis of Host Cell Proteins for Biopharmaceutical Process Development

A Fast Strategy for Profiling and Identifying Pharmaceutic Excipient Polysorbates by Ultra-High Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry.

Tailoring polishing steps for effective removal of polysorbate‐degrading host cell proteins in antibody purification

Novel High-Throughput Assay for Polysorbate Quantification in Biopharmaceutical Products by Using the Fluorescent Dye DiI

High-Throughput Characterization and Optimization of Polyamide Hydrolase Activity Using Open Port Sampling Interface Mass Spectrometry.

Activity-Based Hydrazine Probes for Protein Profiling of Electrophilic Functionality in Therapeutic Targets

Novel Strategy to Rapidly Profile and Identify Oxidized Species of Polysorbate 80 Using Ultra-High-Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry

Monitoring polysorbate hydrolysis in biopharmaceuticals using a QC-ready free fatty acid quantification method

High throughput multidimensional liquid chromatography approach for online protein removal and characterization of polysorbates and poloxamer in monoclonal antibody formulations